Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Mani Inc (7730 JP)
Watchlist
48
Analysis
Health Care
•
Japan
MANI, INC. manufactures medical goods and equipment. The Company's products include threads and needles for surgeries, surgical knives for eye surgeries, and dental instruments and equipment.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
11 Oct 2026 08:30
APAC Healthcare Weekly (Oct 11) – Shionogi, Terumo, Ono Pharma, Celltrion, Hanmi Pharm, CSL
Shionogi is acquiring IntraBio for $2B. Ono stuck inlicensing deal with Biohaven. Hanmi’s obesity drug got approval in Korea. CSL terminates supply...
Tina Banerjee
Follow
89 Views
Share
bullish
•
Mani Inc
•
09 Aug 2026 22:35
Primer: Mani Inc (7730 JP) - Aug 2026
Mani Inc. is a specialized Japanese manufacturer of high-quality medical and dental instruments, holding a strong position in niche global...
αSK Primers
101 Views
Share
bullish
•
Mani Inc
•
20 Jul 2026 08:30
Mani Inc (7730 JP): 9MFY26 Results Underline Recovery, FY26 Guidance Revised Upward
Mani Inc sees revenue growth and margin improvement in 9MFY26. FY26 guidance revised upward for strong financial performance. Ongoing dental...
Tina Banerjee
Follow
139 Views
Share
bullish
•
Mani Inc
•
02 May 2026 08:30
Mani Inc (7730 JP): China Dia-Bur Sale Resumption Positively Impact H1FY26, FY26 Guidance Reiterated
Mani Inc's revenue rise and margin improve in H1FY26. Expects sales recovery and significant uptick in profits for FY26. Going forward, Mani will...
Tina Banerjee
Follow
185 Views
Share
bullish
•
Mani Inc
•
19 Jan 2026 08:30
Mani Inc (7730 JP): Margins Expand in Q1FY26, Dia-Bur Sale Resume in China, FY26 Guidance Reiterated
Mani Inc saw revenue growth and margin improvement in Q1FY26, expects full recovery in sales with dia-bur resumption in China and reiterated FY26...
Tina Banerjee
Follow
298 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x